 | This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (February 2017) |
| Company type | Public |
|---|---|
| Traded as | Nasdaq: SSKN |
| Founded | 1 January 1989  |
| Headquarters | Horsham, Pennsylvania, Pennsylvania, United States |
| Website | strataskinsciences.com |
Strata Skin Sciences (formerly MELA Sciences, Inc.) is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union.
In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County.
References
- "Mela Sciences, no more; Company rebrands as Strata Skin Science". MassDevice. 2015-12-22. Retrieved 2021-02-19.
- "Case - Mela Sciences Inc". Pomeranz Law. Archived from the original on 26 September 2013. Retrieved 17 November 2012.
- George, John. "Exclusive: N.Y. medical device firm moving to Montco" Philadelphia Business Journal (July 15, 2015)
 | This article about a corporation or company specializing in health technology is a stub. You can help Misplaced Pages by expanding it. |